Physician profile
Vijay Nath
NPI 1730183377
$5,618.63
in general payments reported to CMS, 2019-2025
31 companies · $804 in 2025
The $804 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $192 · 2021: $294 · 2022: $457 · 2023: $2,281 · 2024: $1,003 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,655 · Honoraria: $1,400 · Education: $33.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,655.44 |
| Honoraria | $1,400.00 |
| Education | $33.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,043.34 | 2019-2023 | Krystexxa |
| Fresenius USA Marketing, INC. | $431.58 | 2019-2024 | Velphoro |
| Astrazeneca Pharmaceuticals LP | $415.66 | 2019-2024 | Farxiga, Lokelma, Evusheld |
| Novartis Pharmaceuticals Corporation | $319.89 | 2024-2025 | |
| Amgen INC. | $310.67 | 2019-2024 | Krystexxa, Tavneos, Parsabiv |
| Travere Therapeutics, INC. | $241.96 | 2022-2025 | Thiola |
| Otsuka America Pharmaceutical, INC. | $221.15 | 2019-2025 | Jynarque |
| Mallinckrodt Hospital Products INC. | $178.17 | 2020-2025 | Terlivaz |
| Vifor Pharma, INC. | $175.35 | 2019-2025 | Veltassa, Korsuva |
| Calliditas Therapeutics US INC. | $158.55 | 2023-2025 | Tarpeyo |
| Aurinia Pharma U.S., INC. | $158.05 | 2022-2025 | Lupkynis |
| Procyrion, INC. | $136.28 | 2024 | |
| Nxstage Medical, INC. | $108.41 | 2025 | Nxstage Cartridge Express, Nxstage System One, Nxstage Pureflow Solution |
| Daiichi Sankyo INC. | $86.27 | 2019-2025 | Injectafer |
| Lilly USA, LLC | $75.22 | 2023-2025 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $68.14 | 2023-2024 | Benlysta |
| Alexion Pharmaceuticals, INC. | $67.97 | 2019-2024 | Ultomiris |
| Mallinckrodt Enterprises LLC | $60.75 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.66 | 2023-2024 | |
| Akebia Therapeutics INC | $52.23 | 2019 | |
| Ardelyx, INC. | $40.38 | 2025 | Ibsrela |
| Alnylam Pharmaceuticals INC. | $35.74 | 2023 | Oxlumo |
| Janssen Pharmaceuticals, INC | $29.50 | 2019 | |
| Cycle Pharmaceuticals INC | $23.19 | 2025 | Ormalvi |
| Opko Pharmaceuticals, LLC | $22.46 | 2024 | Rayaldee |
| Ani Pharmaceuticals, INC. | $20.00 | 2025 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $18.72 | 2019 | |
| Shire North American Group INC | $18.21 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.72 | 2024 | Jardiance |
| Nuwellis, INC. | $15.89 | 2019 | |
| La Jolla Pharmaceutical Company | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Nath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.